Energize Pharmaceutical Program Partners with X-ELIO for Renewable Energy Initiatives

Energize Pharmaceutical Program Partners with X-ELIO



The pharmaceutical industry is increasingly focused on sustainability, and the Energize program exemplifies this commitment through innovative partnerships. Recently, X-ELIO, a global leader in renewable energy, announced a significant collaboration with major players in the pharmaceutical sector. This agreement enables Thermo Fisher Scientific, Haleon, Gilead Sciences, and GSK to purchase 245 GWh of renewable energy annually over the next decade.

The partnership is anchored in a multi-buyer Power Purchase Agreement (PPA), which represents a flexible and strategic approach to sourcing renewable energy. It allows the participating companies to collectively meet their decarbonization goals while fostering a sustainable environment. The energy supplied will derive from X-ELIO's Lorca Solar project, projected to commence operations by early 2026.

Mirko Molinari, Chief Commercial Officer at X-ELIO, emphasized the value of this agreement, stating that it highlights their commitment to personalized net-zero solutions that align with their partners' needs. He expressed enthusiasm about contributing to the Energize program and helping to decarbonize the supply chain in the pharmaceutical and healthcare sectors.

X-ELIO is not just about energy; it incorporates a strong social and local commitment into its renewable projects. The Lorca Solar project includes a comprehensive Community Plan, focusing on enhancing the local area's quality of life. This plan encompasses initiatives such as donating educational resources like books and musical instruments to schools, establishing virtual classrooms, providing professional training programs, and sponsoring vital cultural and sporting events.

The Energize program, which this partnership supports, is a groundbreaking initiative spearheaded by Schneider Electric's Sustainability Business. It aims to revolutionize supply chain practices by encouraging renewable energy sourcing. Backed by the Pharmaceutical Supply Chain Initiative (PSCI), the program includes numerous sponsoring companies such as Almirall, Amgen, AstraZeneca, and many more, showcasing the industry's united front against climate challenges.

Since its inception, Energize has made significant strides towards integrating renewable energy into the pharmaceutical industry. The latest collaboration with X-ELIO marks a milestone as companies explore innovative approaches to sustainability that align with corporate responsibilities and environmental stewardship. X-ELIO's vast experience and commitment to reducing greenhouse gas emissions further reinforce the program's objectives of cultivating an eco-friendly business environment.

X-ELIO, which operates under Brookfield's ownership, has established itself as a key player in renewable energy development globally, with successful projects in Spain, Italy, the U.S., Japan, and more. With a legacy of over 20 years and a portfolio exceeding 3 GW of energy produced, the company is dedicated to battling climate change and enhancing sustainability across industries.

As companies like those in the Energize program increasingly focus on sustainable practices, it’s clear that the collaboration with X-ELIO will play a vital role in advancing comprehensive climate goals within the pharmaceutical sector. This partnership not only promotes renewable energy consumption but also encourages corporate social responsibility and community welfare, marking a significant movement towards an eco-conscious future.

For more information about X-ELIO and the Energize program, visit their respective websites or follow their updates online.

Topics Energy)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.